» Articles » PMID: 37957294

Achieving Net-zero in the Dry Eye Disease Care Pathway

Overview
Journal Eye (Lond)
Specialty Ophthalmology
Date 2023 Nov 13
PMID 37957294
Authors
Affiliations
Soon will be listed here.
Abstract

Climate change is a threat to human health and wellbeing across the world. In recent years, there has been a surge in awareness of this crisis, leading to many countries and organisations setting "net-zero" targets. This entails minimising carbon emissions and neutralising remaining emissions by removing carbon from the atmosphere. At the 2022 United Nations Climate Change Conference (COP27), commitments to transition away from fossil fuels and augment climate targets were underwhelming. It is therefore imperative for public and private sector organisations to demonstrate successful implementation of net-zero and set a precedent for the global political consensus. As a top 10 world employer, the United Kingdom National Health Service (NHS) has pledged to reach net-zero by 2045. The NHS has already taken positive steps forward, but its scale and complexity as a health system means stakeholders in each of its services must highlight the specifications for further progress. Dry eye disease is a chronic illness with an estimated global prevalence of 29.5% and an environmentally damaging care pathway. Moreover, environmental damage is a known aggravator of dry eye disease. Worldwide management of this illness generates copious amounts of non-recyclable waste, utilises inefficient supply chains and involves recurrent follow-up appointments and prescriptions. By mapping the dry eye disease care pathway to environmental impact, in this review we will highlight seven key areas in which reduced emissions and pollution could be targeted. Examining these approaches for improved environmental sustainability is critical in driving the transformation needed to preserve our health and wellbeing.

Citing Articles

Patients' perspective on the environmental impact of the severe dry eye disease healthcare pathway.

Latham S, Boddy L, McClay T, Airaldi M, Borgia A, Cordos A Eye (Lond). 2025; .

PMID: 40089624 DOI: 10.1038/s41433-025-03747-9.


An Assessment of the Ocular Toxicity of Two Major Sources of Environmental Exposure.

Rauchman S, Kasselman L, Srivastava A, Leon J, Reiss A Int J Environ Res Public Health. 2024; 21(6).

PMID: 38929026 PMC: 11203412. DOI: 10.3390/ijerph21060780.

References
1.
Bradley J, Simoni J, Bradley R, McCartney D, Brown S . Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops. Cornea. 2009; 28(2):200-5. DOI: 10.1097/ICO.0b013e318186321e. View

2.
Yu Y, Chow D, Lau C, Zhou G, Back W, Xu J . A bioinspired synthetic soft hydrogel for the treatment of dry eye. Bioeng Transl Med. 2021; 6(3):e10227. PMC: 8459603. DOI: 10.1002/btm2.10227. View

3.
Simmons P, Liu H, Carlisle-Wilcox C, Vehige J . Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial. Clin Ophthalmol. 2015; 9:665-75. PMC: 4404880. DOI: 10.2147/OPTH.S78184. View

4.
Sherry B, Lee S, Ramos Cadena M, Laynor G, Patel S, dellaBadia Simon M . How Ophthalmologists Can Decarbonize Eye Care: A Review of Existing Sustainability Strategies and Steps Ophthalmologists Can Take. Ophthalmology. 2023; 130(7):702-714. PMC: 10293062. DOI: 10.1016/j.ophtha.2023.02.028. View

5.
Ferrero A, Thouvenin R, Hoogewoud F, Marcireau I, Offret O, Louison P . The carbon footprint of cataract surgery in a French University Hospital. J Fr Ophtalmol. 2021; 45(1):57-64. DOI: 10.1016/j.jfo.2021.08.004. View